
Independent institutional research identifying structural risk and asymmetric downside in small and micro-cap equities.
– ZenaTech (NASDAQ: ZENA) has advanced approximately C$28.2 million in cash to Epazz (OTC: EPAZ), controlled by ZenaTech CEO Shaun Passleym, for R&D. – ZENA then purchased these developed assets
We see XTIA going to $2-$3 this year, depending on the extent of their cost-cutting and Drone Nerds’
Pulse Biosciences (PLSE) started in 2004 with its Nano-Pulse Stimulation (NPS) technology, and hasn’t found any success in
ZJK Industrial (ZJK) is a Chinese precision fastener company (it makes nuts and bolts), it’s not an AI
Telomir Pharma (TELO) is in the preclinical stage with only one drug, TELOMIR-1, being studied to treat osteoarthritis.
On 4/18/24, Agba Group (AGBA) announced a merger with social media company Triller that they claim is worth
A former authID (AUID) top executive has told us that selfie identification will never be the second factor